The Choosing Wisely guidelines of the Society of Surgical Oncology recommend omission of SLN surgery in patients older than 70 years with small ER-positive HER2-negative breast cancer when the adjuvant treatment plan is clear and does not include the addition of chemotherapy to endocrine treatment. Here, ERBB2 is linked to breast cancer.